compounded semaglutide being discontinued FDA ends shortage, closing the door on Wegovy, Ozempic Compounded Semaglutide: Is it Safe?

Suspected side effects from medicines including those taken as part of a clinical trial can be reported via the MHRA Yellow Card Scheme at yellowcard.mhra.gov.uk or via the Yellow Card app

We are regulated by each individual state board of pharmacy that we are shipping medications to, and we are also regulated by the FDA and DEA to ensure that we are abiding by all the safety standards and are being compliant with the rules and regulations, said Empower CEO & Founder Shaun Noorian

Retatrutide is an investigational triple agonist targeting GLP-1, GIP, and glucagon receptors, currently under clinical development for obesity and type 2 diabetes

Its approved for people aged 10 and older